Bulut, T. Et Al. 2016. Omalizumab treatment decreased IL 1 and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma. EAACI - European Academy of Allergy and Clinical Immunology congress , (Viyana, Austria).

Bulut, T., Yalçın, A. D., Çelik, B., GENÇ, G. E., Köse, Ş., GÖÇMEN, A. Y., ... Kiraz, K.(2016). Omalizumab treatment decreased IL 1 and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma . EAACI - European Academy of Allergy and Clinical Immunology congress, Viyana, Austria

Bulut, Tangül Et Al. "Omalizumab treatment decreased IL 1 and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma," EAACI - European Academy of Allergy and Clinical Immunology congress, Viyana, Austria, 2016

Bulut, Tangül Et Al. "Omalizumab treatment decreased IL 1 and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma." EAACI - European Academy of Allergy and Clinical Immunology congress , Viyana, Austria, 2016

Bulut, T. Et Al. (2016) . "Omalizumab treatment decreased IL 1 and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma." EAACI - European Academy of Allergy and Clinical Immunology congress , Viyana, Austria.

@conferencepaper{conferencepaper, author={Tangül Bulut Et Al. }, title={Omalizumab treatment decreased IL 1 and irisin but increased chemerin without any impact on NK cells and APC cells in cases of severe asthma}, congress name={EAACI - European Academy of Allergy and Clinical Immunology congress}, city={Viyana}, country={Austria}, year={2016}}